(Sharecast News) - Crystal Amber said on Wednesday that its portfolio company Morphic Medical has secured commercial registration from the UK Medicines and Healthcare products Regulatory Agency for its 'RESET' endoscopic treatment for obesity and type 2 diabetes, paving the way for UK sales.
The AIM-traded firm said the milestone followed...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE